SCHEMBL1318906

SCHEMBL1318906

CCCCOc1nc(Cl)nc(Cl)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
NPC1 O15118 1/20 0.41
HSD17B10 Q99714 1/20 0.41
KDM4E B2RXH2 1/20 0.40
NFKB1 P19838 1/20 0.40
CYP3A4 P08684 3/20 0.37
CYP2D6 P10635 1/20 0.37
TLR7 Q9NYK1 2/20 0.36
PTGS1 P23219 1/20 0.35
PTGS2 P35354 1/20 0.35
LTA4H P09960 2/20 0.35
ALDH1A1 P00352 1/20 0.35
ALOX15 P16050 1/20 0.35
TSHR P16473 1/20 0.35
CYP1A2 P05177 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
NR5A1 Q13285 1/20 0.34
MCHR1 Q99705 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6051629 0.96 RAB9A (0.41) RAB9ASMN1; SMN2NPC1HSD17B10KDM4E
SCHEMBL5381295 0.94 SOAT1 (0.37) RAB9ASMN1; SMN2NPC1HSD17B10KDM4E
SCHEMBL17563551 0.92 NR5A1 (0.40) LTA4HALDH1A1TSHRNR5A1MCHR1
SCHEMBL11393908 0.92 NR5A1 (0.40) LTA4HALDH1A1TSHRNR5A1MCHR1
SCHEMBL11652521 0.92 NR5A1 (0.40) LTA4HALDH1A1TSHRNR5A1MCHR1
SCHEMBL17486055 0.88 NR5A1 (0.40) LTA4HALDH1A1TSHRNR5A1MCHR1
SCHEMBL11390156 0.88 NR5A1 (0.40) LTA4HALDH1A1TSHRNR5A1MCHR1
SCHEMBL11395631 0.88 NR5A1 (0.40) LTA4HALDH1A1TSHRNR5A1MCHR1
SCHEMBL11387091 0.88 NR5A1 (0.40) LTA4HALDH1A1TSHRNR5A1MCHR1
SCHEMBL11391229 0.88 NR5A1 (0.40) LTA4HALDH1A1TSHRNR5A1MCHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12577215-B2 Triazine UV absorbers and a process for the preparation thereof BASF SE (DE) 2026-03-17 US disclosed
US-20230088507-A1 TRIAZINE UV ABSORBERS AND A PROCESS FOR THE PREPARATION THEREOF BASF SE (DE) 2023-03-23 US disclosed
EP-4081510-A1 TRIAZINE UV ABSORBERS AND A PROCESS FOR THE PREPARATION THEREOF BASF SE (DE) 2022-11-02 EP disclosed
CN-114901645-A Triazine UV absorbent and preparation method thereof 巴斯夫欧洲公司 2022-08-12 CN disclosed
WO-2021130380-A1 TRIAZINE UV ABSORBERS AND A PROCESS FOR THE PREPARATION THEREOF BASF SE (DE) 2021-07-01 WO disclosed
US-9126954-B2 Hydroxy group protecting agent and hydroxy group protection method NATIONAL UNIVERSITY CORPORATION KANAZAWA UNIVERSITY (JP) 2015-09-08 US disclosed
US-20140343281-A1 HYDROXY GROUP PROTECTING AGENT AND HYDROXY GROUP PROTECTION METHOD NATIONAL UNIVERSITY CORPORATION KANAZAWA UNIVERSITY (JP) 2014-11-20 US disclosed
US-8330039-B2 Solar cell modules with poly(vinyl butyral) encapsulant comprising unsaturated heterocyclic compound E I DU PONT DE NEMOURS AND COMPANY (US) 2012-12-11 US disclosed
US-20110275640-A1 Preventives or remedies for alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound BTG INTERNATIONAL LTD. (GB) 2011-11-10 US disclosed
US-20110275641-A1 Preventives or remedies for Alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound BTG INTERNATIONAL LTD. (GB) 2011-11-10 US disclosed
US-5236698-A S-TRIAZINE DERIVATIVES CARRYING BENZALMALONATE SUBSTITUENTS, AND COSMETIC UV SCREENING COMPOSITIONS L'OREAL (FR) 1993-08-17 US disclosed
EP-0507691-A1 S-triazine derivatives substituted with benzalmalonates, process for their preparation, filtering cosmetic compositions containing them and their use as UV-protectors for skin and hair L'OREAL (FR) 1992-10-07 EP disclosed
EP-0279122-B1 REACTIVE DYES IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1992-06-10 EP disclosed
US-5039799-A Light, heat, oxidation stabilizer CIBA-GEIGY CORPORATION (US) 1991-08-13 US disclosed
EP-0365469-A1 Piperidine-triazine compounds for use as stabilizers for organic materials CIBA-GEIGY AG (CH) 1990-04-25 EP disclosed
EP-0356014-A1 Reactive Dyes ZENECA LIMITED (GB) 1990-02-28 EP disclosed
EP-0045721-B1 PIPERIDYL DERIVATIVES OF TRIAZINE COPOLYMERS, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS STABILISED WITH SUCH DERIVATIVES CIBA-GEIGY S.p.A. (IT) 1985-05-08 EP disclosed
EP-0117229-A1 Piperidinyl-triazine compounds, for use as stabilizers for synthetic polymers CIBA-GEIGY S.p.A. (IT) 1984-08-29 EP disclosed
US-4459395-A LIGHT, HEAT, AND OXIDATION STABILIZERS FOR POLYOLEFINS CHIMOSA CHIMICA ORGANICA S.P.A. (IT) 1984-07-10 US disclosed
EP-0045721-A2 Piperidyl derivatives of triazine copolymers, process for their preparation and compositions stabilised with such derivatives CIBA-GEIGY S.p.A. (IT) 1982-02-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140343281-A1 HYDROXY GROUP PROTECTING AGENT AND HYDROXY GROUP PROTECTION METHOD OGG1, HAO2, HAAO RAB9A 4350/4885SMN1; SMN2 2776/4885NPC1 3096/4885
US-20110275641-A1 Preventives or remedies for Alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound APP, BACE1, PSEN1 RAB9A 2624/4885SMN1; SMN2 2462/4885NPC1 27/4885
US-12577215-B2 Triazine UV absorbers and a process for the preparation thereof CYP2R1, NR2E3, SRD5A2 RAB9A 3026/4885SMN1; SMN2 3869/4885NPC1 371/4885
US-20230088507-A1 TRIAZINE UV ABSORBERS AND A PROCESS FOR THE PREPARATION THEREOF NISCH, DHPS, UMPS RAB9A 3985/4885SMN1; SMN2 4768/4885NPC1 1024/4885
US-20110275640-A1 Preventives or remedies for alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound APP, BACE1, PSEN1 RAB9A 2624/4885SMN1; SMN2 2462/4885NPC1 27/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.